Skip to content
← Full study record

NCT00295880 · MORE INFO

Limitations, agreements, and source contact

Donor Umbilical Cord Blood Transplant By Injection Into the Bone Marrow in Treating Patients With Hematologic Cancer · Source last updated 2017-12-28

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

certain Agreement
pi Sponsor Employee
true
restrictive Agreement
false
limitations And Caveats
description
This study was terminated early based on interim statistical analysis that indicated time to engraftment will not be improved compared to historical controls. While safe, lack of faster marrow recovery supports early discontinuation.
point Of Contact
email
wagne002@umn.edu
organization
Masonic Cancer Center, University of Minnesota Blood and Marrow Transplant Program
phone
612-626-2961
title
John E. Wagner, M.D.
Complete source fields
certain Agreement
pi Sponsor Employee
true
restrictive Agreement
false
limitations And Caveats
description
This study was terminated early based on interim statistical analysis that indicated time to engraftment will not be improved compared to historical controls. While safe, lack of faster marrow recovery supports early discontinuation.
point Of Contact
email
wagne002@umn.edu
organization
Masonic Cancer Center, University of Minnesota Blood and Marrow Transplant Program
phone
612-626-2961
title
John E. Wagner, M.D.

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice